in millions of euros, unless otherwise stated, | |||
for the year ended December 31 | 2023 | 2022 | |
Revenues | Note 5/6 | ||
Cost of revenues | Note 5 | ( | ( |
Gross profit | Note 5 | ||
Sales costs | Note 9 | ( | ( |
General and administrative costs | Note 10 | ( | ( |
Total operating expenses | Note 5 | ( | ( |
Other gains and (losses) | Note 11 | ( | |
Operating profit | Note 5 | ||
Financing income | |||
Financing costs | ( | ( | |
Other finance income and (costs) | ( | ||
Total financing results | Note 14 | ( | ( |
Share of profit of equity-accounted associates, net of tax | Note 20 | ||
Profit before tax | |||
Income tax expense | Note 15 | ( | ( |
Profit for the year | |||
Attributable to: | |||
– Owners of the company | |||
– Non-controlling interests | Note 16 | ||
Profit for the year | |||
Earnings per share (EPS) (€) | |||
Basic EPS | Note 7 | ||
Diluted EPS | Note 7 |
in millions of euros, | |||
for the year ended December 31 | 2023 | 2022 | |
Comprehensive income | |||
Profit for the year | |||
Other comprehensive income | |||
Items that are or may be reclassified subsequently to the consolidated statement ofprofitorloss: | |||
Exchange differences on translation of foreign operations | ( | ||
Exchange differences on translation of equity-accounted | |||
associates | Note 20 | ( | |
Recycling of foreign exchange differences on loss of control | Note 8 | ||
Gains/(losses) on hedges of net investments in foreign operations | ( | ||
Gains/(losses) on cash flow hedges | ( | ||
Net change in fair value of cash flow hedges reclassified to the consolidated statementofprofit or loss | Note 14 | ||
Items that will not be reclassified to the consolidated | |||
statement of profit or loss: | |||
Remeasurement gains/(losses) on defined benefit plans | Note 30 | ( | |
Other comprehensive income/(loss) for the year, before tax | ( | ||
Income tax on items that are or may be reclassified | |||
subsequently to the consolidated statement ofprofit or loss | |||
Income tax on items that will not be reclassified to the consolidated statement of profit orloss | ( | ||
Income tax on other comprehensive income | Note 22 | ( | |
Other comprehensive income/(loss) for the year | ( | ||
Total comprehensive income for the year | |||
Attributable to: | |||
– Owners of the company | |||
– Non-controlling interests | |||
Total comprehensive income for the year |
in millions of euros, for the year ended December 31 | 2023 | 2022 | |
Cash flows from operating activities | |||
Profit for the year | |||
Adjustments for: | |||
Income tax expense | Note 15 | ||
Share of profit of equity-accounted associates, net of tax | Note 20 | ( | |
Financing results | Note 14 | ||
Amortization, impairment, and depreciation | Note 13 | ||
Book (profit)/loss on disposal of operations and non-current | |||
assets | ( | ( | |
Fair value changes of contingent considerations | Note 11/29 | ||
Additions to and releases from provisions | Note 31 | ||
Appropriation of provisions | Note 31 | ( | ( |
Changes in employee benefit provisions | ( | ||
Share-based payments | Note 12/33 | ||
Other adjustments | |||
Adjustments excluding autonomous movements in working capital | |||
Inventories | ( | ( | |
Contract assets | Note 24 | ( | ( |
Trade and other receivables | |||
Deferred income | Note 24 | ||
Other contract liabilities | Note 24 | ||
Trade and other payables | |||
Assets/liabilities classified as held for sale | ( | ||
Autonomous movements in working capital | |||
Total adjustments | |||
Net cash flows from operations | |||
Interest paid (including the interest portion of lease payments) | ( | ( | |
Interest received | |||
Paid income tax | Note 22 | ( | ( |
Net cash from operating activities |
in millions of euros, for the year ended December 31 | 2023 | 2022 | |
Cash flows from investing activities | |||
Capital expenditure | Note 17/18 | ( | ( |
Proceeds from disposal of other intangible assets and property, plant, and equipment | |||
Acquisition spending, net of cash acquired | Note 8 | ( | ( |
Receipts from divestments, net of cash disposed | Note 8 | ||
Dividends received | |||
Cash used for settlement of net investment hedges | ( | ||
Net cash used in investing activities | ( | ( | |
Cash flows from financing activities | |||
Repayment of loans | ( | ( | |
Proceeds from new loans | |||
Repayment of principal portion of lease liabilities | Note 19 | ( | ( |
Repurchased shares | Note 32 | ( | ( |
Dividends paid | Note 32 | ( | ( |
Net cash used in financing activities | ( | ( | |
Net cash flows before effect of exchange differences | ( | ||
Exchange differences on cash and cash equivalents and bank | |||
overdrafts | ( | ||
Net change in cash and cash equivalents and bank overdrafts | ( | ||
Cash and cash equivalents less bank overdrafts at January 1 | |||
Cash and cash equivalents less bank overdrafts at December 31 | Note 26 | ||
Add: Bank overdrafts at December 31 | Note 26 | ||
Cash and cash equivalents in the consolidated statement of financial position at December 31 | Note 26 |
in millions of euros, at December 31 | 2023 | 2022 | |
Non-current assets | |||
Goodwill | Note 17 | ||
Intangible assets other than goodwill | Note 17 | ||
Property, plant, and equipment | Note 18 | ||
Right-of-use assets | Note 19 | ||
Investments in equity-accounted associates | Note 20 | ||
Financial assets | Note 21 | ||
Non-current other receivables | Note 25 | ||
Non-current contract assets | Note 24 | ||
Deferred tax assets | Note 22 | ||
Total non-current assets | |||
Current assets | |||
Inventories | Note 23 | ||
Contract assets | Note 24 | ||
Trade receivables | Note 24 | ||
Other receivables | Note 25 | ||
Current income tax assets | Note 22 | ||
Cash and cash equivalents | Note 26/28 | ||
Total current assets | |||
Total assets |
in millions of euros, at December 31 | 2023 | 2022 | |
Equity | |||
Issued share capital | Note 32 | ||
Share premium reserve | |||
Legal reserves | |||
Treasury shares | ( | ( | |
Retained earnings | |||
Equity attributable to the owners of the company | Note 46 | ||
Non-controlling interests | Note 16 | ||
Total equity | |||
Non-current liabilities | |||
Bonds | |||
Private placements | |||
Lease liabilities | |||
Other long-term debt | |||
Total long-term debt | Note 28 | ||
Deferred tax liabilities | Note 22 | ||
Employee benefits | Note 30 | ||
Provisions | Note 31 | ||
Non-current deferred income | Note 24 | ||
Total non-current liabilities | |||
Current liabilities | |||
Deferred income | Note 24 | ||
Other contract liabilities | Note 24 | ||
Trade and other payables | Note 27 | ||
Current income tax liabilities | Note 22 | ||
Short-term provisions | Note 31 | ||
Borrowings and bank overdrafts | Note 28 | ||
Short-term bonds | Note 28 | ||
Short-term lease liabilities | Note 28 | ||
Total current liabilities | |||
Total liabilities | |||
Total equity and liabilities |
Legal reserves | Other reserves | |||||||||
Issued | Share | Non- | ||||||||
share | premium | Legal reserve | Hedge | Translation | Treasury | Retained | Shareholders’ | controlling | ||
in millions of euros | capital | reserve | participations | reserve | reserve | shares | earnings | equity | interests | Total equity |
Balance at January 1, 2022 | ( | ( | ||||||||
Profit for the year | ||||||||||
Other comprehensive income/(loss) for the year | ||||||||||
Total comprehensive income for theyear | ||||||||||
Transactions with owners of the company, recognized directly | ||||||||||
in equity: | ||||||||||
Share-based payments | ||||||||||
Cancelation of shares | ( | ( | ||||||||
Release LTIP shares | ( | |||||||||
Final cash dividend 2021 | ( | ( | ( | |||||||
Interim cash dividend 2022 | ( | ( | ( | |||||||
Repurchased shares | ( | ( | ( | |||||||
Other movements | ( | |||||||||
Balance at December 31, 2022 | ( | ( | ||||||||
Balance at January 1, 2023 | ( | ( | ||||||||
Profit for the year | ||||||||||
Other comprehensive income/(loss) for the year | ( | ( | ( | ( | ( | |||||
Total comprehensive income for theyear | ( | ( | ||||||||
Transactions with owners of the company, recognized directly | ||||||||||
in equity: | ||||||||||
Share-based payments | ||||||||||
Cancelation of shares | ( | ( | ||||||||
Release LTIP shares | ( | |||||||||
Final cash dividend 2022 | ( | ( | ( | |||||||
Interim cash dividend 2023 | ( | ( | ( | |||||||
Repurchased shares | ( | ( | ( | |||||||
Other movements | ( | |||||||||
Balance at December 31, 2023 | ( | ( |
Allocated | Pro-forma | Allocated | ||
goodwill in | Reallocation | goodwill in | goodwill in | |
groups of cash-generating units | 2022 | of goodwill | 2022 | 2023 |
Health Learning, Research & Practice | 567 | (567) | ||
Clinical Solutions (Health) | 557 | (557) | ||
Health | 1,124 | 1,124 | 1,111 | |
Tax & Accounting Americas and Asia Pacific | 1,131 | (1,131) | ||
Tax & Accounting Europe | 411 | (411) | ||
Tax & Accounting | 1,213 | 1,213 | 1,188 | |
Financial & Corporate Compliance | 1,122 | (102) | 1,020 | 987 |
Legal & Regulatory | 606 | (37) | 569 | 573 |
Corporate Performance & ESG | 468 | 468 | 463 | |
Total | 4,394 | 0 | 4,394 | 4,322 |
Main currency exchange rates | ||
rates to the euro | 2023 | 2022 |
U.S. dollar (average) | 1.08 | 1.05 |
U.S. dollar (at December 31) | 1.11 | 1.07 |
Note 5 – Segment reporting | ||||||||||||||
Financial & | ||||||||||||||
Tax & | Corporate | Legal & | Corporate | |||||||||||
in millions of euros, unless otherwise stated | Health | Accounting | Compliance | Regulatory | Performance & ESG | Corporate | Total | |||||||
reporting by segment | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
Revenues from contracts with third parties | 1,508 | 1,448 | 1,466 | 1,394 | 1,052 | 1,056 | 875 | 916 | 683 | 639 | – | – | 5,584 | 5,453 |
Cost of revenues | (460) | (444) | (399) | (378) | (247) | (269) | (257) | (282) | (213) | (205) | – | – | (1,576) | (1,578) |
Gross profit | 1,048 | 1,004 | 1,067 | 1,016 | 805 | 787 | 618 | 634 | 470 | 434 | 0 | 0 | 4,008 | 3,875 |
Sales costs | (237) | (231) | (217) | (217) | (134) | (137) | (148) | (161) | (193) | (168) | – | – | (929) | (914) |
General and administrative costs | (401) | (396) | (388) | (363) | (286) | (282) | (358) | (366) | (250) | (226) | (66) | (64) | (1,749) | (1,697) |
Total operating expenses | (638) | (627) | (605) | (580) | (420) | (419) | (506) | (527) | (443) | (394) | (66) | (64) | (2,678) | (2,611) |
Other gains and (losses) | (4) | (1) | (2) | (2) | (2) | (5) | 2 | 78 | (1) | (1) | – | 0 | (7) | 69 |
Operating profit | 406 | 376 | 460 | 434 | 383 | 363 | 114 | 185 | 26 | 39 | (66) | (64) | 1,323 | 1,333 |
Amortization of acquired identifiable intangible assets | 44 | 37 | 17 | 19 | 18 | 19 | 26 | 26 | 41 | 39 | – | – | 146 | 140 |
Impairment of acquired identifiable intangible assets | – | 20 | – | – | – | – | – | – | – | – | – | – | 0 | 20 |
Non-benchmark items in operating profit | 4 | 1 | 2 | 2 | 2 | 5 | (2) | (78) | 1 | 1 | – | 0 | 7 | (69) |
Adjusted operating profit | 454 | 434 | 479 | 455 | 403 | 387 | 138 | 133 | 68 | 79 | (66) | (64) | 1,476 | 1,424 |
Amortization of other intangible assets and depreciation of PPE and right-of-use assets | (47) | (46) | (77) | (81) | (46) | (48) | (62) | (61) | (62) | (56) | 0 | 0 | (294) | (292) |
Impairment of other intangible assets, PPE, and right-of-use assets | 0 | (6) | (2) | (5) | 0 | (2) | (1) | (1) | (2) | 0 | – | – | (5) | (14) |
Goodwill and acquired identifiable intangible assets at December 31 | 1,260 | 1,300 | 1,284 | 1,321 | 1,159 | 1,217 | 725 | 743 | 766 | 813 | – | – | 5,194 | 5,394 |
Net capital expenditure | 49 | 42 | 74 | 67 | 58 | 52 | 58 | 61 | 84 | 73 | 0 | 0 | 323 | 295 |
Number of FTEs at December 31 | 3,333 | 3,116 | 7,276 | 6,693 | 3,056 | 3,112 | 4,033 | 3,892 | 3,215 | 3,111 | 143 | 132 | 21,056 | 20,056 |
Total non-current assets per geographic region | ||||
2023 | 2022 | |||
in millions of euros, unless otherwise stated | % | % | ||
715 | 11 | 676 | 11 | |
Europe (excluding the Netherlands) | 1,302 | 21 | 1,336 | 21 |
U.S. and Canada | 4,176 | 67 | 4,338 | 67 |
Asia Pacific | 76 | 1 | 85 | 1 |
Rest of World | 20 | 0 | 19 | 0 |
Total | 6,289 | 100 | 6,454 | 100 |
Note 6 – Revenues | ||
2023 | 2022 | |
Revenues from contracts with third parties | 5,584 | 5,453 |
Disaggregation of revenues | ||||||||||||
Revenues by recognition pattern and contract length | Tax & | Financial & Corporate | Legal & | Corporate Performance | ||||||||
Health | Accounting | Compliance | Regulatory | & ESG | Total | |||||||
reporting per segment | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
Revenue per recognition pattern | ||||||||||||
At a point in time recognition | 253 | 253 | 193 | 186 | 366 | 371 | 246 | 262 | 103 | 68 | 1,161 | 1,140 |
Over time recognition | 1,255 | 1,195 | 1,273 | 1,208 | 686 | 685 | 629 | 654 | 580 | 571 | 4,423 | 4,313 |
Revenues from contracts with third parties | 1,508 | 1,448 | 1,466 | 1,394 | 1,052 | 1,056 | 875 | 916 | 683 | 639 | 5,584 | 5,453 |
Revenue per contract length | ||||||||||||
Contracts one year or less | 963 | 953 | 1,279 | 1,236 | 844 | 858 | 644 | 705 | 354 | 337 | 4,084 | 4,089 |
Multi-year contracts | 545 | 495 | 187 | 158 | 208 | 198 | 231 | 211 | 329 | 302 | 1,500 | 1,364 |
Revenues from contracts with third parties | 1,508 | 1,448 | 1,466 | 1,394 | 1,052 | 1,056 | 875 | 916 | 683 | 639 | 5,584 | 5,453 |
Revenues by media format | Tax & | Financial & Corporate | Legal & | Corporate Performance | ||||||||
Health | Accounting | Compliance | Regulatory | & ESG | Total | |||||||
reporting per segment | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
Digital | 1,348 | 1,281 | 1,398 | 1,322 | 558 | 567 | 736 | 746 | 683 | 639 | 4,723 | 4,555 |
Services | 4 | 1 | 33 | 34 | 488 | 484 | 9 | 14 | 0 | 0 | 534 | 533 |
Print | 156 | 166 | 35 | 38 | 6 | 5 | 130 | 156 | – | – | 327 | 365 |
Revenues from contracts with third parties | 1,508 | 1,448 | 1,466 | 1,394 | 1,052 | 1,056 | 875 | 916 | 683 | 639 | 5,584 | 5,453 |
Recurring/non-recurring revenues | ||||||||||||
Tax & | Financial & Corporate | Legal & | Corporate Performance | |||||||||
Health | Accounting | Compliance | Regulatory | & ESG | Total | |||||||
reporting per segment | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
Recurring revenues | 1,374 | 1,307 | 1,339 | 1,287 | 704 | 676 | 683 | 708 | 443 | 410 | 4,543 | 4,388 |
Non-recurring revenues | 134 | 141 | 127 | 107 | 348 | 380 | 192 | 208 | 240 | 229 | 1,041 | 1,065 |
Revenues from contracts with third parties | 1,508 | 1,448 | 1,466 | 1,394 | 1,052 | 1,056 | 875 | 916 | 683 | 639 | 5,584 | 5,453 |
Revenues by type | ||||
Digital and service subscription | 4,134 | 2023 | 3,950 | 2022 |
Print subscription | 136 | 157 | ||
Other recurring | 273 | 281 | ||
Total recurring revenues | 4,543 | 4,388 | ||
Print books | 120 | 129 | ||
Legal Services transactional | 283 | 299 | ||
Financial Services transactional | 128 | 134 | ||
Other non-recurring | 510 | 503 | ||
Total non-recurring revenues | 1,041 | 1,065 | ||
Revenues from contracts with third parties | 5,584 | 5,453 |
Revenues per geographic region | ||||
2023 | 2022 | |||
in millions of euros, unless otherwise stated | % | % | ||
The Netherlands | 227 | 4 | 204 | 4 |
Europe (excluding the Netherlands) | 1,342 | 24 | 1,356 | 25 |
U.S. and Canada | 3,577 | 64 | 3,476 | 64 |
Asia Pacific | 345 | 6 | 333 | 6 |
Rest of World | 93 | 2 | 84 | 1 |
Revenues from contracts with third parties | 5,584 | 100 | 5,453 | 100 |
Profit for the year | |||
2023 | 2022 | ||
Profit for the year attributable to the owners of the company (A) | 1,007 | 1,027 | |
Weighted-average number of ordinary shares for the year | |||
in millions of shares, unless otherwise stated | 2023 | 2022 | |
Outstanding ordinary shares at January 1 | Note 32 | 257.5 | 262.5 |
Effect of cancelation of shares | (3.4) | (1.9) | |
Effect of repurchased shares | (9.2) | (5.9) | |
Weighted-average number of ordinary shares (B) | 244.9 | 254.7 | |
Basic EPS (A/B) (€) | 4.11 | 4.03 |
Diluted weighted-average number of ordinary shares for the year | ||
in millions of shares, unless otherwise stated | 2023 | 2022 |
Weighted-average number of ordinary shares (B) | 244.9 | 254.7 |
Effect of long-term incentive plan (LTIP) | 1.1 | 1.1 |
Diluted weighted-average number of ordinary shares (C) | 246.0 | 255.8 |
Diluted EPS (A/C) (€) | 4.09 | 4.01 |
Acquisitions | |||||
2023 | 2022 | ||||
Carrying | Fair value | Recognized | Recognized | ||
amounts | adjustments | values | values | ||
Consideration payable in cash | 60 | 92 | |||
Deferred and contingent | |||||
considerations at fair value: | |||||
Non-current | 2 | 2 | |||
Current | 2 | 1 | |||
Total consideration | 64 | 95 | |||
Intangible assets other than goodwill | Note 17 | 1 | 50 | 51 | 77 |
Other non-current assets | Note 19 | 0 | 0 | 2 | |
Current assets | 7 | 7 | 4 | ||
Current liabilities | (9) | (9) | (2) | ||
Non-current liabilities | Note 28 | (1) | (1) | (2) | |
Deferred tax assets/(liabilities) | 0 | (10) | (10) | (19) | |
Fair value of net identifiable assets | (2) | 40 | 38 | 60 | |
Goodwill on acquisitions | Note 17 | 26 | 35 | ||
Cash effect of acquisitions: | |||||
Consideration payable in cash | 60 | 92 | |||
Cash acquired | (2) | (1) | |||
Deferred and contingent | |||||
considerations paid | Note 29 | 3 | 1 | ||
Acquisition spending, net of cash | |||||
acquired | 61 | 92 |
Contribution of 2023 acquisitions | ||||
Adjusted | FTEs at | |||
operating | Profit for | December | ||
in millions of euros, unless otherwise stated | Revenues | profit | the year | 31, 2023 |
Totals excluding the impact of 2023 acquisitions | 5,570 | 1,475 | 1,009 | 20,947 |
Contribution of 2023 acquisitions | 14 | 1 | (2) | 109 |
Totals for the year 2023 | 5,584 | 1,476 | 1,007 | 21,056 |
Pro forma contribution of 2023 acquisitions for the period January 1, 2023, up to acquisition date | ||||
(unaudited) | 5 | 1 | (3) | |
Pro forma totals for the year 2023 | 5,589 | 1,477 | 1,004 | 21,056 |
Divestment-related results on operations and financial assets | |||
2023 | 2022 | ||
Divestment of operations: | |||
Consideration receivable in cash | 5 | 114 | |
Consideration receivable | 5 | 114 | |
Intangible assets | – | 0 | |
Other non-current assets | – | 0 | |
Current assets (including assets held for sale) | – | 110 | |
Current liabilities (including liabilities held for sale) | – | (77) | |
Deferred tax assets/(liabilities) | 1 | 0 | |
Net identifiable assets/(liabilities) | 1 | 33 | |
Reclassification of foreign exchange differences on loss of control to profit or loss, previously recognized in other comprehensive income | – | (1) | |
Book profit/(loss) on divestments of operations | 4 | 80 | |
Divestment-related costs | 0 | (3) | |
Restructuring of stranded costs following divestments | Note 31 | – | (2) |
Divestment-related results included in other gains and (losses) | Note 11 | 4 | 75 |
Divestment of financial assets | |||
Consideration receivable in cash | 3 | – | |
Carrying value of financial assets | 0 | – | |
Divestment-related results included in total financing results | Note 14 | 3 | 0 |
Cash effect of divestments: | |||
Consideration receivable in cash | 8 | 114 | |
Cash included in divested operations | – | (8) | |
Receipts from divestments, net of cash disposed | 8 | 106 |
Note 9 – Sales costs | |||
2023 | 2022 | ||
Marketing and promotion costs | 253 | 263 | |
Sales-related costs – sales commissions directly expensed | 157 | 162 | |
Sales-related costs – amortization of capitalized sales commissions | Note 24 | 29 | 29 |
Other sales-related costs | 383 | 359 | |
Customer support costs | 84 | 80 | |
Additions to and releases from loss allowances on trade receivables | |||
and unbilled revenues | Note 24 | 23 | 21 |
Total | 929 | 914 |
Note 10 – General and administrative costs | |||
2023 | 2022 | ||
Research, development, and editorial costs | 591 | 541 | |
General and administrative operating expenses | 1,012 | 996 | |
Amortization and impairment of acquired identifiable | |||
intangible assets | Note 13 | 146 | 160 |
Total | 1,749 | 1,697 |
Note 11 – Other gains and (losses) | |||
2023 | 2022 | ||
Acquisition-related costs | Note 8 | (7) | (3) |
Additions to acquisition integration provisions | Note 31 | (4) | (3) |
Fair value changes of contingent considerations | Note 29 | 0 | 0 |
Divestment-related results | Note 8 | 4 | 75 |
Total | (7) | 69 |
Note 12 – Employee benefit expenses | |||
in millions of euros, unless otherwise stated | 2023 | 2022 | |
Salaries and wages and other benefits | 1,848 | 1,769 | |
Social security charges | 161 | 159 | |
Medical cost benefits | 101 | 94 | |
Expenses related to defined contribution plans | 96 | 89 | |
Expenses related to defined benefit plans | Note 30 | 16 | 29 |
Equity-settled share-based payments | Note 33 | 31 | 28 |
Total | 2,253 | 2,168 |
Employees | ||
Headcount at December 31 | 21,438 | 20,511 |
Thereof employed in the Netherlands | 1,176 | 1,150 |
In full-time equivalents at December 31 | 21,056 | 20,056 |
In full-time equivalents average per annum | 20,810 | 20,061 |
Note 13 – Amortization, impairment, and depreciation | |||
2023 | 2022 | ||
Amortization of acquired identifiable intangible assets | Note 17 | 146 | 140 |
Impairment of acquired identifiable intangible assets | Note 17 | – | 20 |
Amortization of other intangible assets | Note 17 | 204 | 195 |
Impairment of other intangible assets | Note 17 | 5 | 13 |
Depreciation of property, plant, and equipment | Note 18 | 23 | 26 |
Impairment of property, plant, and equipment | Note 18 | 0 | 1 |
Depreciation of right-of-use assets | Note 19 | 67 | 71 |
Total | 445 | 466 |
Note 14 – Financing results | |||
Financing income | 2023 | 2022 | |
Interest income for financial assets measured at amortized cost: | |||
Interest income on short-term bank deposits | 50 | 20 | |
Interest income on bank balances and other Other financing income: | 5 | 1 | |
Derivatives – foreign exchange contracts, not qualifying as hedge | 0 | 0 | |
Total financing income | 55 | 21 | |
Financing costs | |||
Interest expense for financial liabilities measured at amortized cost: | |||
Interest expense on Euro Commercial Paper program and bank | |||
borrowings | (3) | 0 | |
Interest expense on bonds and private placements | (68) | (54) | |
Amortization of fee expense for debt instruments | Note 28 | (3) | (3) |
Interest expense on bank overdrafts and other Other financing expense: | (3) | (3) | |
Unwinding of discount of lease liabilities | Note 28 | (9) | (9) |
Net foreign exchange gains/(losses) | 7 | (5) | |
Items in hedge relationships: | |||
Interest rate swaps | (3) | (3) | |
Foreign exchange gains/(losses) on loans subject to cash flow hedge | 15 | 11 | |
Net change in fair value of cash flow hedges reclassified from other comprehensive income | (15) | (11) | |
Total financing costs | (82) | (77) | |
Net financing results | (27) | (56) | |
Other finance income and (costs) | |||
Divestment-related results on financial assets | Note 8 | 3 | – |
Fair value changes of financial assets | Note 21 | 0 | 0 |
Financing component employee benefits | Note 30 | (3) | (1) |
Total other finance income and (costs) | 0 | (1) | |
Total financing results | (27) | (57) |
Note 15 – Income tax expense | |||||
2023 | 2022 | ||||
Current income tax expense | 300 | 286 | |||
Adjustments previous years | (2) | (13) | |||
Deferred tax expense: | |||||
Changes in tax rates | 0 | 0 | |||
Origination and reversal of temporary differences | (8) | (24) | |||
Movements in deferred tax assets and liabilities | Note 22 | (8) | (24) | ||
Total | Note 22 | 290 | 249 |
2023 | 2022 | |||
in millions of euros, unless otherwise stated | % | % | ||
Profit before tax | 1,297 | 1,276 | ||
Income tax expense at the Dutch statutory income | ||||
tax rate | 25.8 | 335 | 25.8 | 329 |
Tax effect of: | ||||
Rate differential | (2.9) | (38) | (2.7) | (35) |
Tax incentives, exempt income, and divestments | (0.8) | (10) | (2.4) | (31) |
Recognized and unrecognized tax losses | 0.0 | 0 | (0.1) | (1) |
Adjustments previous years | (0.1) | (2) | (1.0) | (13) |
Changes in income tax rates | 0.0 | 0 | 0.0 | 0 |
Other taxes | 0.9 | 11 | 0.9 | 11 |
Non-deductible costs and other items | (0.5) | (6) | (1.0) | (11) |
Total | 22.4 | 290 | 19.5 | 249 |
ownership in % | 2023 | 2022 |
Akadémiai Kiadó Kft. (Budapest, Hungary) | 74 | 74 |
Note 17 – Goodwill and intangible assets other than goodwill | ||||||||||
Acquired | ||||||||||
identifiable | Other | |||||||||
Customer | Technology | intangible | intangible | |||||||
Position at January 1 | Goodwill | relationships | and content | Brand names | Other | assets | assets | 2023 | 2022 | |
Cost value | 4,394 | 1,134 | 808 | 494 | 3 | 2,439 | 2,011 | 8,844 | 8,498 | |
Accumulated amortization and impairment | – | (579) | (432) | (425) | (3) | (1,439) | (1,363) | (2,802) | (2,698) | |
Book value at January 1 | 4,394 | 555 | 376 | 69 | 0 | 1,000 | 648 | 6,042 | 5,800 | |
Movements | ||||||||||
Investments | – | – | – | – | – | 0 | 298 | 298 | 264 | |
Acquired through business combinations | Note 8 | 26 | 27 | 23 | 0 | – | 50 | 1 | 77 | 112 |
Disposal of assets | – | – | – | – | – | 0 | 0 | 0 | 0 | |
Net expenditures | 26 | 27 | 23 | 0 | 0 | 50 | 299 | 375 | 376 | |
Amortization | Note 13 | – | (70) | (65) | (11) | 0 | (146) | (204) | (350) | (335) |
Impairment | Note 13 | – | – | – | – | – | 0 | (5) | (5) | (33) |
Reclassifications | Note 8 | 9 | – | (13) | – | – | (13) | 1 | (3) | 2 |
Foreign exchange differences | (107) | (10) | (8) | (1) | 0 | (19) | (13) | (139) | 232 | |
Total movements | (72) | (53) | (63) | (12) | 0 | (128) | 78 | (122) | 242 | |
Position at December 31 | ||||||||||
Cost value | 4,322 | 1,105 | 690 | 457 | 3 | 2,255 | 2,083 | 8,660 | 8,844 | |
Accumulated amortization and impairment | – | (603) | (377) | (400) | (3) | (1,383) | (1,357) | (2,740) | (2,802) | |
Book value at December 31 | 4,322 | 502 | 313 | 57 | 0 | 872 | 726 | 5,920 | 6,042 |
Acquired | ||||
identifiable | Pro-forma | |||
Goodwill | intangible assets | 2023 | 2022 | |
Health | 1,111 | 149 | 1,260 | 1,300 |
Tax & Accounting | 1,188 | 96 | 1,284 | 1,321 |
Financial & Corporate Compliance | 987 | 172 | 1,159 | 1,217 |
Legal & Regulatory | 573 | 152 | 725 | 743 |
Corporate Performance & ESG | 463 | 303 | 766 | 813 |
Total | 4,322 | 872 | 5,194 | 5,394 |
2023 | 2022 | |
Risk-free rate United States (in %) | 4.2 | 3.6 |
Risk-free rate Europe (in %) | 2.8 | 2.1 |
Market risk premium United States (in %) | 5.5 | 6.0 |
Market risk premium Europe (in %) | 6.0 | 6.8 |
Tax rate United States (in %) | 26.0 | 26.0 |
Tax rate Europe (in %) | 25.8 | 25.8 |
Re-levered beta | 0.80 | 0.79 |
Applied | Allowed change (in basis points) | ||||
weighted- | Decrease | Allocated | |||
2023 sensitivity per group of CGUs | average | Decline | Increase | in adjusted | goodwill at |
in millions of euros, unless otherwise | growth | in growth | in discount | operating | December |
stated | rate | rate | rate | profit margin | 31, 2023 |
Health | 2.3% | >300 | >300 | >300 | 1,111 |
Tax & Accounting | 2.2% | >300 | >300 | >300 | 1,188 |
Financial & Corporate Compliance | 2.3% | >300 | >300 | >300 | 987 |
Legal & Regulatory | 2.3% | >300 | >300 | >300 | 573 |
Corporate Performance & ESG | 2.2% | >300 | >300 | >300 | 463 |
Total | 2.3% | 4,322 |
Applied | Allowed change (in basis points) | ||||
weighted- | Decrease | Allocated | |||
2022 sensitivity per group of CGUs | average | Decline | Increase | in adjusted | goodwill at |
in millions of euros, unless otherwise | growth | in growth | in discount | operating | December 31, |
stated | rate | rate | rate | profit margin | 2022 |
Health Learning, Research & Practice | 2.1% | >300 | >300 | >300 | 567 |
Clinical Solutions | 2.2% | >300 | >300 | >300 | 557 |
Tax & Accounting Americas and Asia Pacific | 2.1% | >300 | >300 | >300 | 1,131 |
Tax & Accounting Europe | 2.0% | >300 | >300 | >300 | 411 |
Financial & Corporate Compliance | 2.2% | >300 | >300 | >300 | 1,122 |
Legal & Regulatory | 2.2% | >300 | >300 | >300 | 606 |
Total | 2.2% | 4,394 |
2023 | 2022 | ||
Acquired identifiable intangible assets – certain assets within Health | – | 20 | |
Other intangible assets | 5 | 13 | |
Total | Note 13 | 5 | 33 |
Land and | |||||
Position at January 1 | buildings | Other PPE | 2023 | 2022 | |
Cost value | 121 | 196 | 317 | 380 | |
Accumulated depreciation and impairment | (87) | (151) | (238) | (305) | |
Book value at January 1 | 34 | 45 | 79 | 75 | |
Movements | |||||
Investments | 5 | 21 | 26 | 28 | |
Acquired through business | |||||
combinations | Note 8 | – | 0 | 0 | – |
Disposal of assets | – | (1) | (1) | 0 | |
Net expenditures | 5 | 20 | 25 | 28 | |
Depreciation | Note 13 | (6) | (17) | (23) | (26) |
Impairment | Note 13 | 0 | 0 | 0 | (1) |
Foreign exchange differences | (1) | (1) | (2) | 3 | |
Total movements | (2) | 2 | 0 | 4 | |
Position at December 31 | |||||
Cost value | 92 | 176 | 268 | 317 | |
Accumulated depreciation and impairment | (60) | (129) | (189) | (238) | |
Book value at December 31 | 32 | 47 | 79 | 79 |
Movement schedule of right-of-use assets | |||||
Other | |||||
Position at January 1 | Real estate | leases | 2023 | 2022 | |
Cost value | 596 | 89 | 685 | 658 | |
Accumulated depreciation and impairment | (338) | (64) | (402) | (357) | |
Book value at January 1 | 258 | 25 | 283 | 301 | |
Movements | |||||
Additions from new leases | 16 | 11 | 27 | 27 | |
Acquired through business combinations | Note 8 | 0 | – | 0 | 2 |
Additions from contract modifications and reassessment of options | 7 | 1 | 8 | 27 | |
Other movements from contract | |||||
modifications and reassessment of options | (3) | (1) | (4) | (14) | |
Net additions | 20 | 11 | 31 | 42 | |
Depreciation | Note 13 | (50) | (17) | (67) | (71) |
Foreign exchange differences | (6) | 0 | (6) | 11 | |
Total movements | (36) | (6) | (42) | (18) | |
Position at December 31 | |||||
Cost value | 575 | 48 | 623 | 685 | |
Accumulated depreciation and impairment | (353) | (29) | (382) | (402) | |
Book value at December 31 | 222 | 19 | 241 | 283 |
Contractual maturities of lease liabilities | |||
2023 | 2022 | ||
Within one year | 65 | 69 | |
Between one and two years | 55 | 59 | |
Between two and three years | 44 | 50 | |
Between three and four years | 36 | 40 | |
Between four and five years | 30 | 34 | |
Between five and ten years | 72 | 86 | |
Ten years and more | 1 | 10 | |
Effect of discounting | (31) | (35) | |
Total lease liabilities at December 31 | Note 28 | 272 | 313 |
Cash outflow for leases | 2023 | 2022 | |
Interest portion of lease payments | 9 | 9 | |
Repayment of principal portion of lease liabilities | 65 | 72 | |
Total | 74 | 81 |
ownership in % | 2023 | 2022 |
Haoyisheng (Beijing, China) | 22 | 22 |
Movement schedule of equity-accounted associates | ||
2023 | 2022 | |
Position at January 1 | 11 | 10 |
Share of profit of equity-accounted associates, net of tax | 1 | 0 |
Foreign exchange differences | (1) | 1 |
Position at December 31 | 11 | 11 |
Total equity-accounted | ||||
associates | Group’s share | |||
2023 | 2022 | 2023 | 2022 | |
Total assets | 38 | 34 | 8 | 8 |
Total liabilities | 22 | 17 | 5 | 4 |
Total equity | 16 | 17 | 3 | 4 |
Revenues | 30 | 31 | 6 | 7 |
Net profit for the year | 3 | 1 | 1 | 0 |
Note 21 – Financial assets | |||
2023 | 2022 | ||
Financial assets at fair value through profit or loss | 0 | 0 | |
Finance lease receivables | 1 | 1 | |
Derivative financial instruments | Note 29 | – | 17 |
Other non-current financial assets | 5 | 5 | |
Total | 6 | 23 |
Deferred tax assets and liabilities | ||||
temporary differences arising from: | Assets | Liabilities | 2023 | 2022 |
Intangible assets | 6 | (398) | (392) | (395) |
Property, plant, and equipment, right-of-use | ||||
assets, and lease liabilities | 79 | (58) | 21 | 17 |
Employee benefits | 45 | (8) | 37 | 38 |
Tax value of loss carry-forwards recognized | 23 | – | 23 | 31 |
Other items | 102 | (21) | 81 | 72 |
Total before set-off of tax | 255 | (485) | (230) | (237) |
Set-off of tax | (204) | 204 | 0 | 0 |
Position at December 31 | 51 | (281) | (230) | (237) |
Movements in temporary differences 2023 | ||||||
Recognized | Recognized in | |||||
Balance at | in profit or | equity and OCI | Foreign | Balance at | ||
January 1, | Acquisitions/ | loss | comprehensive | exchange | December | |
2023 | divestments | (Note 15) | income | differences | 31, 2023 | |
Intangible assets | (395) | (7) | 1 | – | 9 | (392) |
PPE, right-of-use | ||||||
assets, and lease | ||||||
liabilities | 17 | – | 4 | – | 0 | 21 |
Employee benefits | 38 | – | 0 | 0 | (1) | 37 |
Tax value of loss carry- forwards recognized | 31 | – | (7) | – | (1) | 23 |
Other items | 72 | (1) | 10 | 0 | 0 | 81 |
Total | (237) | (8) | 8 | 0 | 7 | (230) |
Movements in temporary differences 2022 | ||||||
Recognized | Recognized in | |||||
Balance at | in profit or | equity and OCI | Foreign | Balance at | ||
January 1, | Acquisitions/ | loss | comprehensive | exchange | December | |
2022 | divestments | (Note 15) | income | differences | 31, 2022 | |
Intangible assets | (390) | (19) | 31 | – | (17) | (395) |
PPE, right-of-use | ||||||
assets, and lease | ||||||
liabilities | 1 | – | 16 | – | 0 | 17 |
Employee benefits | 37 | – | 4 | (5) | 2 | 38 |
Tax value of loss carry- forwards recognized | 38 | – | (9) | – | 2 | 31 |
Other items | 82 | 0 | (18) | 4 | 4 | 72 |
Total | (232) | (19) | 24 | (1) | (9) | (237) |
Movements in overall tax position | |||
Position at January 1 | 2023 | 2022 | |
Current income tax assets | 61 | 59 | |
Current income tax liabilities | (129) | (142) | |
Deferred tax assets | 62 | 62 | |
Deferred tax liabilities | (299) | (294) | |
Overall tax position | (305) | (315) | |
Movements | |||
Total income tax expense | Note 15 | (290) | (249) |
Deferred tax from acquisitions and divestments | (8) | (19) | |
Current income tax from acquisitions and divestments | 0 | (1) | |
Deferred tax on items recognized directly in OCI | 0 | (1) | |
Paid income tax | 325 | 289 | |
Foreign exchange differences | 6 | (9) | |
Total movements | 33 | 10 | |
Position at December 31 | |||
Current income tax assets | 86 | 61 | |
Current income tax liabilities | (128) | (129) | |
Deferred tax assets | 51 | 62 | |
Deferred tax liabilities | (281) | (299) | |
Overall tax position | (272) | (305) |
Deferred tax on items recognized immediately in other comprehensive income and equity | ||||||
2023 | 2022 | |||||
Amount | Amount | Amount | Amount | |||
before | net of | before | net of | |||
Exchange differences on translation of foreign operations, recycling of foreign | tax | Tax | tax | tax | Tax | tax |
exchange differences on loss of control, and net investment hedges | (124) | 0 | (124) | 216 | 4 | 220 |
Gains/(losses) on cash flow hedges | (7) | – | (7) | 29 | – | 29 |
Remeasurement gains/(losses) on defined | ||||||
benefit plans | (1) | 0 | (1) | 18 | (5) | 13 |
Recognized in other comprehensive income | (132) | 0 | (132) | 263 | (1) | 262 |
Share-based payments | 31 | – | 31 | 28 | – | 28 |
Recognized in equity | 31 | 0 | 31 | 28 | 0 | 28 |
Note 23 – Inventories | ||
2023 | 2022 | |
Work in progress | 27 | 27 |
Finished products and trade goods | 57 | 52 |
Total | 84 | 79 |
2023 | 2022 | |
Trade receivables | 1,087 | 1,088 |
Non-current contract assets | 18 | 17 |
Current contract assets | 160 | 153 |
Non-current deferred income | 102 | 112 |
Current deferred income | 1,899 | 1,858 |
Other current contract liabilities | 86 | 88 |
Loss allowances | |||
2023 | 2022 | ||
Position at January 1 | 85 | 83 | |
Additions to loss allowances | Note 9 | 34 | 33 |
Releases from loss allowances | Note 9 | (11) | (12) |
Usage of loss allowances | (22) | (22) | |
Foreign exchange differences | (1) | 3 | |
Position at December 31 | 85 | 85 |
Contract assets | ||||||
Cost to | Cost to | |||||
Unbilled | obtain a | fulfill a | ||||
current and non-current | revenues | contract | contract | 2023 | 2022 | |
Position at January 1 | 101 | 41 | 28 | 170 | 157 | |
Recognized as revenues in the year | 502 | – | – | 502 | 465 | |
Newly recognized cost to fulfill a contract | – | – | 519 | 519 | 473 | |
Transferred to trade receivables | (501) | – | (506) | (1,007) | (932) | |
Newly recognized cost to obtain a contract | – | 30 | – | 30 | 28 | |
Amortization of capitalized sales | ||||||
commissions | Note 9 | – | (29) | – | (29) | (29) |
Autonomous movements in contract | ||||||
assets | 1 | 1 | 13 | 15 | 5 | |
Acquired through business | ||||||
combinations | Note 8 | – | – | – | 0 | 1 |
Foreign exchange differences | (5) | (1) | (1) | (7) | 7 | |
Position at December 31 | 97 | 41 | 40 | 178 | 170 |
Deferred income | |||
current and non-current | 2023 | 2022 | |
Position at January 1 | 1,970 | 1,822 | |
New and existing contracts with customers | 4,300 | 3,944 | |
Recognized as revenues from opening balance | (1,858) | (1,709) | |
Recognized as revenues in the year on new and existing contracts | (2,309) | (2,137) | |
Change in netting against trade receivables | (53) | (25) | |
Autonomous movements in deferred income | 80 | 73 | |
Acquired through business combinations | Note 8 | 6 | 0 |
Foreign exchange differences | (55) | 75 | |
Position at December 31 | 2,001 | 1,970 |
Other contract liabilities | |||
2023 | 2022 | ||
Position at January 1 | 88 | 80 | |
Additions to provision for returns, refunds, and other | 121 | 140 | |
Usage of provision for returns, refunds, and other | (121) | (136) | |
Autonomous movements in other contract liabilities | 0 | 4 | |
Acquired through business combinations | Note 8 | – | 1 |
Foreign exchange differences | (2) | 3 | |
Position at December 31 | 86 | 88 |
Note 25 – Other receivables | |||
2023 | 2022 | ||
Prepaid royalties | 14 | 16 | |
Non-current other receivables | 14 | 16 | |
Prepaid royalties | 56 | 55 | |
Other prepayments | 116 | 157 | |
VAT, sales tax, and other taxation | 16 | 19 | |
Miscellaneous receivables | 10 | 13 | |
Interest receivable | 2 | 5 | |
Derivative financial instruments | Note 29 | 2 | 1 |
Current other receivables | 202 | 250 |
Note 26 – Cash and cash equivalents | |||
2023 | 2022 | ||
Deposits | 649 | 909 | |
Cash and bank balances | 486 | 437 | |
Total cash and cash equivalents in the consolidated statement | |||
of financial position | 1,135 | 1,346 | |
Minus: Bank overdrafts used for cash management purposes | Note 28 | (146) | (16) |
Total cash and cash equivalents minus bank overdrafts | 989 | 1,330 |
Note 27 – Trade and other payables | |||
2023 | 2022 | ||
Trade payables | 165 | 147 | |
Salaries, holiday allowances, and other benefits | 285 | 276 | |
VAT, sales tax, social security premiums, and other taxation | 91 | 95 | |
Pension-related payables | 28 | 28 | |
Royalty payables | 87 | 88 | |
Other accruals and payables | 295 | 315 | |
Interest payable | 42 | 39 | |
Deferred and contingent acquisition payables | Note 29 | 4 | 2 |
Total | 997 | 990 |
Nominal | |||||||
Effective | interest | Repayment | Repayment | ||||
in millions of euros, unless | Nominal | interest | rate in | commitments | commitments | ||
otherwise stated | value | rate in % | % | 1-5 years | >5 years | 2023 | 2022 |
Bonds 2008-2028 (100.00 * ) | €36 | 6.812 | 6.748 | 36 | – | 36 | 36 |
Bonds 2014-2024 (99.164 * ) | €400 | 2.640 | 2.500 | – | – | 0 | 399 |
Bonds 2017-2027 (99.659 * ) | €500 | 1.575 | 1.500 | 499 | – | 499 | 499 |
Bonds 2020-2030 (99.292 * ) | €500 | 0.862 | 0.750 | – | 496 | 496 | 496 |
Bonds 2021-2028 (99.958 * ) | €500 | 0.307 | 0.250 | 499 | – | 499 | 498 |
Bonds 2022-2026 (99.922 * ) | €500 | 3.096 | 3.000 | 499 | – | 499 | 498 |
Bonds 2023-2031 (99.417 * ) | €700 | 3.877 | 3.750 | – | 694 | 694 | – |
Bonds, measured at amortized cost | 1,533 | 1,190 | 2,723 | 2,426 | |||
Private placements | |||||||
2008-2038, measured at amortized cost | – | 127 | 127 | 142 | |||
Deferred and contingent | |||||||
acquisition payables, measured at fair value | 1 | – | 1 | 2 | |||
Other debt, measured at amortized cost | 21 | – | 21 | 16 | |||
Derivative financial | |||||||
instruments, measured | |||||||
at fair value | – | 5 | 5 | – | |||
Other long-term debt | 22 | 5 | 27 | 18 | |||
Total long-term debt | |||||||
(excluding lease liabilities) | 1,555 | 1,322 | 2,877 | 2,586 | |||
Lease liabilities | 209 | 244 | |||||
Total long-term debt | 3,086 | 2,830 |
Reconciliation long-term debt to net debt | |||
2023 | 2022 | ||
Total long-term debt | 3,086 | 2,830 | |
Borrowings and bank overdrafts: | |||
Euro Commercial Paper program | 50 | – | |
Bank overdrafts, measured at amortized cost | Note 26 | 146 | 16 |
Total borrowings and bank overdrafts | 196 | 16 | |
Bonds 2013-2023 | – | 700 | |
Bonds 2014-2024 | 400 | – | |
Short-term lease liabilities | 63 | 69 | |
Deferred and contingent acquisition payables measured | |||
at fair value | Note 29 | 4 | 2 |
Total short-term debt | 663 | 787 | |
Gross debt | 3,749 | 3,617 | |
Minus: | |||
Cash and cash equivalents | Note 26 | (1,135) | (1,346) |
Derivative financial instruments: | |||
Non-current assets | Note 21 | – | (17) |
Current assets | Note 25 | (2) | (1) |
Net debt | 2,612 | 2,253 |
Lease liabilities | |||||||
current and non current | 2023 | 2022 | |||||
Position at January 1 | 313 | 331 | |||||
Additions from new leases | 27 | 27 | |||||
Acquired through business combinations | Note 8 | 0 | 2 | ||||
Contract modifications and reassessments of options | 4 | 10 | |||||
Repayment of lease liabilities (interest and principal portion) | (74) | (80) | |||||
Unwinding of discount of lease liabilities | Note 14 | 9 | 9 | ||||
Foreign exchange differences | (7) | 14 | |||||
Position at December 31 | 272 | 313 |
2023 | |
2025 | 12 |
2026 | 509 |
2027 | 499 |
2028 | 535 |
Due after 2028 | 1,322 |
Long-term debt | 2,877 |
Short-term debt (2024) | 600 |
Total (excluding lease liabilities) | 3,477 |
2023 | 2022 | |
Revenues | (38) | (37) |
Adjusted operating profit | (13) | (12) |
Operating profit | (12) | (11) |
Adjusted net profit | (8) | (8) |
Profit for the year | (8) | (7) |
Shareholders’ equity at December 31 | (36) | (38) |
Adjusted free cash flow | (11) | (12) |
Exchange | Interest | ||||
in millions, unless | Type of | rate movement | rate movement | ||
otherwise stated | Hedged risk | Amount | instrument | € | € |
Changes in ¥ floating | Cross-currency | ||||
interest payments and | interest | ||||
Cash flow hedge | ¥ exchange rates | ¥20,000 | rate swaps | (1) | (1) |
Changes of the U.S. dollar | |||||
net investments due to | |||||
Net investment | fluctuations of U.S. dollar | Forward | |||
hedge | exchange rates | $275 | contracts | 2 | 0 |
Contractual cash flows 2023 | Contractual cash flows 2022 | ||||||||||||
Contractual | Less | More | Contractual | Less | More | ||||||||
Carrying | undiscounted | than | 1-2 | 2-5 | than | Carrying | undiscounted | than | 1-2 | 2-5 | than | ||
Non-derivative financial liabilities | amount | cash flows | 1 year | years | years | 5 years | Non-derivative financial liabilities | amount | cash flows | 1 year | years | years | 5 years |
(excl. lease liabilities) | (excl. lease liabilities) | ||||||||||||
Bonds: | Bonds: | ||||||||||||
Bonds 2008-2028 | 36 | 47 | 2 | 2 | 43 | – | Bonds 2008-2028 | 36 | 49 | 2 | 2 | 7 | 38 |
Bonds 2014-2024 | 400 | 410 | 410 | – | – | – | Bonds 2013-2023 | 700 | 720 | 720 | – | – | – |
Bonds 2017-2027 | 499 | 531 | 8 | 8 | 515 | – | Bonds 2014-2024 | 399 | 420 | 10 | 410 | – | – |
Bonds 2020-2030 | 496 | 527 | 4 | 4 | 11 | 508 | Bonds 2017-2027 | 499 | 539 | 8 | 8 | 523 | – |
Bonds 2021-2028 | 499 | 506 | 1 | 1 | 504 | – | Bonds 2020-2030 | 496 | 530 | 4 | 4 | 11 | 511 |
Bonds 2022-2026 | 499 | 545 | 15 | 15 | 515 | – | Bonds 2021-2028 | 498 | 507 | 1 | 1 | 4 | 501 |
Bonds 2023-2031 | 694 | 910 | 26 | 26 | 79 | 779 | Bonds 2022-2026 | 498 | 560 | 15 | 15 | 530 | – |
Private placements: | Private placements: | ||||||||||||
Private placements 2008-2038 | 127 | 189 | 4 | 4 | 13 | 168 | Private placements 2008-2038 | 142 | 216 | 5 | 5 | 14 | 192 |
Long- and short-term deferred and | Long- and short-term deferred and | ||||||||||||
contingent acquisition payables | 5 | 5 | 4 | 1 | – | – | contingent acquisition payables | 4 | 4 | 2 | 2 | – | – |
Other debt | 21 | 21 | – | 11 | 10 | – | Other debt | 16 | 16 | – | 8 | 8 | – |
Borrowings and bank overdrafts | 196 | 196 | 196 | – | – | – | Borrowings and bank overdrafts | 16 | 16 | 16 | – | – | – |
Trade payables | 183 | 183 | 183 | – | – | – | Trade payables | 147 | 147 | 147 | – | – | – |
Total | 3,655 | 4,070 | 853 | 72 | 1,690 | 1,455 | Total | 3,451 | 3,724 | 930 | 455 | 1,097 | 1,242 |
Derivative financial instruments | Derivative financial instruments | ||||||||||||
(Receipts) (252) | (252) | (Receipts) | (260) | (260) | |||||||||
Payments | 249 | 249 | Payments | 258 | 258 | ||||||||
Foreign exchange derivatives | (2) | (3) | (3) | 0 | 0 | 0 | Foreign exchange derivatives | (1) | (2) | (2) | 0 | 0 | 0 |
(Receipts) | (189) | (4) | (4) | (13) | (168) | (Receipts) | (216) | (5) | (5) | (14) | (192) | ||
Payments | 238 | 8 | 8 | 23 | 199 | Payments | 245 | 8 | 8 | 23 | 206 | ||
Cross-currency interest rate swaps | 5 | 49 | 4 | 4 | 10 | 31 | Cross-currency interest rate swaps | (17) | 29 | 3 | 3 | 9 | 14 |
Total derivative financial liabilities/(assets) | 3 | 46 | 1 | 4 | 10 | 31 | Total derivative financial liabilities/(assets) | (18) | 27 | 1 | 3 | 9 | 14 |
2023 | 2022 | ||||||
Non-derivative financial instruments: | Carrying value | Fair value | Level 1 | Level 2 | Level 3 | Carrying value | Fair value |
Financial assets at fair value through profit or loss | 0 | 0 | 0 | 0 | 0 | ||
Unbilled revenues | 97 | 97 | 101 | 101 | |||
Trade receivables | 1,087 | 1,087 | 1,088 | 1,088 | |||
Miscellaneous receivables | 10 | 10 | 13 | 13 | |||
Interest receivable | 2 | 2 | 5 | 5 | |||
Cash and cash equivalents | 1,135 | 1,135 | 1,346 | 1,346 | |||
Total non-derivative financial assets | 2,331 | 2,331 | 0 | 2,553 | 2,553 | ||
Bonds 2008-2028 | 36 | 41 | 41 | 36 | 41 | ||
Bonds 2013-2023 | – | – | 700 | 701 | |||
Bonds 2014-2024 | 400 | 398 | 398 | 399 | 396 | ||
Bonds 2017-2027 | 499 | 479 | 479 | 499 | 459 | ||
Bonds 2020-2030 | 496 | 435 | 435 | 496 | 399 | ||
Bonds 2021-2028 | 499 | 449 | 449 | 498 | 417 | ||
Bonds 2022-2026 | 499 | 501 | 501 | 498 | 489 | ||
Bonds 2023-2031 | 694 | 727 | 727 | – | – | ||
Private placements 2008-2038 | 127 | 149 | 149 | 142 | 172 | ||
Long- and short-term deferred and contingent acquisition payables | 5 | 5 | 5 | 4 | 4 | ||
Other debt | 21 | 21 | 16 | 16 | |||
Borrowings and bank overdrafts | 196 | 196 | 16 | 16 | |||
Trade payables | 183 | 183 | 147 | 147 | |||
Interest payable | 42 | 42 | 39 | 39 | |||
Total non-derivative financial liabilities | 3,697 | 3,626 | 3,030 | 149 | 5 | 3,490 | 3,296 |
Derivative financial instruments: | |||||||
Non-current assets | – | – | 17 | 17 | |||
Current assets | 2 | 2 | 2 | 1 | 1 | ||
Total derivative financial assets | 2 | 2 | 2 | 18 | 18 | ||
Non-current liabilities | 5 | 5 | 5 | – | – | ||
Total derivative financial liabilities | 5 | 5 | 5 | 0 | 0 |
2023 | 2022 | ||
Balance at January 1 | 4 | 2 | |
Acquired through business combinations | Note 8 | 4 | 3 |
Settlements | Note 8 | (3) | (1) |
Fair value changes of contingent considerations | Note 11 | 0 | 0 |
Foreign exchange differences | 0 | 0 | |
Balance at December 31 | 5 | 4 |
Fair value | Maximum | Fair value | |||
December 31, | Of which: | Of which: | exposure | December 31, | |
2023 | short term | long term | (undiscounted) | 2022 | |
Total | 5 | 4 | 1 | 5 | 4 |
2023 | 2022 | |
Retirement plans | 29 | 34 |
Other post-employment benefit plans | 45 | 44 |
Other long-term employment benefits | 7 | 7 |
Total | 81 | 85 |
Characteristics of material plans | |||
Retirement plans | The Netherlands | United States | United Kingdom |
Type of benefits | Pensions | Pensions | Pensions |
Type of plan | Career average | Final salary | Final salary |
Status of plan | Open | Frozen | Frozen |
Service costs | Yes | No | No |
Status of plan funding | Funded | Funded | Funded |
Other post-employment plans | Post-retirement | ||
Type of benefits | medical plan | ||
Annual insurance | |||
Type of plan | premium coverage | ||
Status of plan | Closed | ||
Service costs | Yes | ||
Status of plan funding | Unfunded |
in % | 2023 | 2022 |
Retirement plans | ||
Discount rate to discount the obligations at year end | 3.3 | 3.9 |
Discount rate for pension expense | 3.9 | 1.3 |
Expected rate of pension increases (in payment) at year end | 2.6 | 3.1 |
Expected rate of pension increases (in deferral) at year end | 2.5 | 3.1 |
Expected rate of inflation increase for pension expense | 2.1 | 2.3 |
Other post-employment benefit plans | ||
Discount rate to discount the obligations at year end | 4.3 | 4.6 |
Discount rate for pension expense | 4.6 | 2.1 |
Medical cost trend rate | 3.0 | 3.0 |
in years | The Netherlands | United States | United Kingdom |
Life expectancy at age of 65 now – Male | 21.8 | 20.6 | 22.2 |
Life expectancy at age of 65 now – Female | 24.2 | 22.6 | 24.0 |
Life expectancy aged 65 in 20 years – Male | 23.8 | 22.7 | 23.3 |
Life expectancy aged 65 in 20 years – Female | 26.2 | 25.0 | 25.3 |
Sensitivity retirement plans | ||||
Gross service cost | ||||
(excluding interest) | Defined benefit obligations | |||
2023 | Baseline | 19 | 1,352 | |
Decrease of | Increase of | Decrease of | Increase of | |
Change compared to baseline | assumption | assumption | assumption | assumption |
Discount rate (change by 1%) | 7 | (5) | 243 | (189) |
Pension increase rate (change by 0.5%) | (2) | 3 | (91) | 103 |
Inflation increase rate (change by 0.5%) | (3) | 4 | (114) | 131 |
Mortality table (change by one year) | – | 1 | (69) | 54 |
Sensitivity of the defined benefit obligations (DBO) of retirement plans in the consolidated | |||||
statement of financial position and the defined benefit expense of the retirement plans | |||||
in the consolidated statement of profit or loss (P&L) | The Netherlands | United States | United Kingdom | ||
DBO | P&L | DBO | P&L | DBO | P&L |
Discount rate sensitivity | – | – | |||
Pension increase sensitivity | – | – | – | ||
Inflation rate sensitivity | – | – | – | ||
Mortality sensitivity | – | – |
Sensitivity of other post-employment plans | |||
Gross service costs | |||
(excluding interest) | Defined benefit obligations | ||
2023 | Baseline | 1 | 45 |
Change compared to baseline | |||
Discount rate (by -1%) | 0 | (4) | |
Discount rate (by +1%) | 0 | 3 |
Defined benefit | Other post- | |||||||||
Plan liabilities and plan assets | retirement plans | employment plans | ||||||||
Defined benefit | Other post- | 2023 | 2022 | 2023 | 2022 | |||||
retirement plans | employment plans | Pension expenses | ||||||||
2023 | 2022 | 2023 | 2022 | Employer service cost | 13 | 19 | 1 | 1 | ||
Plan liabilities | Settlement gain | – | 0 | – | – | |||||
Fair value at January 1 | 1,263 | 1,645 | 44 | 52 | Past service costs – plan amendment | – | 7 | – | – | |
Settlements | – | (2) | – | – | Interest expense on irrecoverable surplus | 0 | 0 | – | – | |
Employer service cost | 13 | 19 | 1 | 1 | Interest expense on defined benefit obligations | 48 | 24 | 2 | 1 | |
Interest expense on defined benefit obligations | 48 | 24 | 2 | 1 | Interest income on plan assets | (47) | (24) | – | – | |
Administration costs and taxes | 2 | 2 | – | – | Administration costs and taxes | 2 | 2 | 0 | – | |
Benefits paid by fund | (54) | (50) | – | – | Total pension expense | 16 | 28 | 3 | 2 | |
Benefits paid by employer | – | – | (3) | (4) | Of which is included in: | |||||
Remeasurement (gains)/losses | 78 | (386) | 2 | (8) | Employee benefit expenses | Note 12 | 15 | 28 | 1 | 1 |
Acquired through business combinations | – | – | 0 | – | Other finance (income)/costs | Note 14 | 1 | 0 | 2 | 1 |
Contributions by plan participants | 4 | 3 | – | – | ||||||
Plan amendments and curtailments | – | 7 | – | – | ||||||
Foreign exchange differences | (2) | 1 | (1) | 2 | ||||||
Fair value at December 31 | 1,352 | 1,263 | 45 | 44 | ||||||
Plan assets | ||||||||||
Fair value at January 1 | 1,240 | 1,641 | 0 | 0 | ||||||
Settlements | – | (2) | – | – | ||||||
Interest income on plan assets | 47 | 24 | – | – | ||||||
Return on plan assets greater than discount rate | 82 | (390) | – | 0 | ||||||
Benefits paid by fund | (54) | (50) | (3) | (4) | ||||||
Contributions by employer | 19 | 13 | 3 | 4 | ||||||
Contributions by plan participants | 4 | 3 | – | – | ||||||
Foreign exchange differences | (1) | 1 | – | – | ||||||
Fair value at December 31 | 1,337 | 1,240 | 0 | 0 | ||||||
Funded status | ||||||||||
Deficit/(surplus) at December 31 | 15 | 23 | 45 | 44 | ||||||
Irrecoverable surplus | 14 | 11 | – | – | ||||||
Net liability at December 31 | 29 | 34 | 45 | 44 |
2023 | 2022 | |
Position at January 1 | (120) | (138) |
Recognized in other comprehensive income | (1) | 18 |
Cumulative amount at December 31 | (121) | (120) |
Remeasurement gains/(losses) for the year | ||
2023 | 2022 | |
Remeasurement gains/(losses) due to experience adjustments | (62) | (17) |
Remeasurement gains/(losses) due to changes in demographic assumptions | 3 | (11) |
Remeasurement gains/(losses) due to changes in financial assumptions | (21) | 422 |
Remeasurement gains/(losses) on defined benefit obligations | (80) | 394 |
Return on plan assets greater/(lower) than discount rate | 82 | (390) |
Change in irrecoverable surplus, other than interest and foreign | ||
exchange differences | (3) | 14 |
Recognized remeasurement gains on defined benefit plans in other comprehensive income | (1) | 18 |
number of years | 2023 | 2022 |
Retirement plans | ||
The Netherlands | 16.7 | 16.9 |
United Kingdom | 11.5 | 11.4 |
United States | 9.3 | 9.8 |
Other post-employment plans | ||
United States | 6.7 | 7.1 |
Equity | 2023 | Quoted | Unquoted | 2022 | Quoted | Unquoted |
Equity | 355 | 355 | – | 333 | 333 | – |
Private equity | 1 | – | 1 | 2 | – | 2 |
Bonds | ||||||
Government bonds | 476 | 476 | – | 406 | 406 | – |
Corporate bonds | 183 | 183 | – | 194 | 194 | – |
Other bonds | 11 | 11 | – | – | – | – |
Asset-backed securities | 87 | 87 | – | 90 | 90 | – |
Other Insurance contracts | 130 | – | 130 | 124 | – | 124 |
Real estate | 93 | 42 | 51 | 95 | 39 | 56 |
Derivatives and other securities | (20) | (20) | – | (32) | (32) | – |
Cash | 21 | 21 | – | 28 | 28 | – |
Total | 1,337 | 1,155 | 182 | 1,240 | 1,058 | 182 |
Proportion of plan assets | ||
in % | 2023 | 2022 |
Equity | 27 | 27 |
Bonds | 57 | 56 |
Other | 16 | 17 |
Total | 100 | 100 |
Note 31 – Provisions | ||
2023 | 2022 | |
Provision for restructuring commitments | 7 | 5 |
Provision for acquisition integration | 1 | 0 |
Restructuring provisions | 8 | 5 |
Legal provisions | 12 | 13 |
Other provisions | 6 | 6 |
Total | 26 | 24 |
Of which short term | 21 | 19 |
Movements in provisions | ||||||
Restructuring | Legal | Other | ||||
Long-term provisions at | provisions | provisions | provisions | 2023 | 2022 | |
January 1 | 1 | 0 | 4 | 5 | 7 | |
Add: short-term provisions | 4 | 13 | 2 | 19 | 27 | |
Total provisions at January 1 | 5 | 13 | 6 | 24 | 34 | |
Movements | ||||||
Additions for restructuring | ||||||
of stranded costs | Note 8 | – | – | – | 0 | 2 |
Additions for acquisition | ||||||
integration | Note 11 | 4 | – | – | 4 | 3 |
Other additions | 8 | 1 | 1 | 10 | 9 | |
Total additions | 12 | 1 | 1 | 14 | 14 | |
Appropriation of provisions | (9) | (1) | 0 | (10) | (15) | |
Release of provisions | 0 | (1) | (1) | (2) | (9) | |
Exchange differences | 0 | 0 | 0 | 0 | 0 | |
Total movements | 3 | (1) | 0 | 2 | (10) | |
Total provisions at December 31 | 8 | 12 | 6 | 26 | 24 | |
Less: short-term provisions | (8) | (11) | (2) | (21) | (19) | |
Long-term provisions at December 31 | 0 | 1 | 4 | 5 | 5 |
Number of shares | ||||||
Number of | Minus: number of | Total number of ordinary | ||||
ordinary shares | treasury shares | shares outstanding | ||||
in thousands of shares, unless | ||||||
otherwise stated | 2023 | 2022 | 2023 | 2022 | 2023 | 2022 |
At January 1 | 257,516 | 262,516 | (8,802) | (4,324) | 248,714 | 258,192 |
Cancelation of shares | (9,000) | (5,000) | 9,000 | 5,000 | 0 | 0 |
Repurchased shares | – | – | (8,738) | (10,128) | (8,738) | (10,128) |
Long-term incentive plan | – | – | 535 | 650 | 535 | 650 |
At December 31 | 248,516 | 257,516 | (8,005) | (8,802) | 240,511 | 248,714 |
Issued share capital at €0.12 (€’000) | 29,822 | 30,902 | ||||
Proposed dividend per share (€) | 2.08 | 1.81 | ||||
Proposed dividend distribution | ||||||
(€’000) | 502,722 | 453,421 |
Dividend distributions over financial year | |||
2023 | 2022 | 2021 | |
Originally proposed dividend over financial year | 503 | 453 | 405 |
Actual payments: | |||
Interim dividend (paid in the financial year) | 176 | 160 | 140 |
Final dividend (paid in the subsequent financial year) | 291 | 264 | |
Total dividend distribution | 451 | 404 |
Note 33 – Share-based payments | ||
2023 | 2022 | |
Long-term incentive plan | 29 | 28 |
Restricted Stock Units | 2 | – |
Total equity-settled share-based payments | 31 | 28 |
Fair value of Adjusted | Fair value | Fair value | |
EPS and ROIC shares | EPS shares | TSR shares | |
in euros | at grant date | at grant date | at grant date |
LTIP 2023-25 | 91.37 | – | 68.72 |
LTIP 2022-24 | 97.82 | – | 71.71 |
LTIP 2021-23 | 64.06 | – | 47.03 |
LTIP 2020-22 | – | 60.68 | 40.85 |
LTIP 2020-22: number of shares vested and the cash equivalent thereof | |||||
Increase in | Increase in | ||||
conditional | conditional | Payout/ | |||
Outstanding | number of | number of | vested shares | Cash value | |
number of shares, | at December 31, | TSR shares | EPS shares | February 23, | vested |
unless otherwise stated | 2022 | (25%) | (50%) | 2023 | shares |
Executive Board | 110,061 | 16,445 | 22,142 | 148,648 | 16,338 |
Senior management | 280,967 | 35,139 | 70,309 | 386,415 | 42,471 |
Total | 391,028 | 51,584 | 92,451 | 535,063 | 58,809 |
LTIP 2021-23 | ||||
Adjusted EPS- | ROIC- | TSR- | ||
number of shares | Total | condition | condition | condition |
Conditionally awarded grant 2021 | 456,649 | 132,695 | 88,463 | 235,491 |
Forfeited in previous years | (37,909) | (11,359) | (7,576) | (18,974) |
Shares outstanding at January 1, 2023 | 418,740 | 121,336 | 80,887 | 216,517 |
Forfeited during the year | (21,981) | (6,595) | (4,397) | (10,989) |
Effect of 150% vesting – EPS-performance | 57,440 | 57,440 | – | – |
Effect of 150% vesting – ROIC-performance | 38,326 | – | 38,326 | – |
Effect of 125% vesting – TSR-ranking | 51,424 | – | – | 51,424 |
Vested at December 31, 2023 | 543,949 | 172,181 | 114,816 | 256,952 |
LTIP 2022-24 | ||||
Adjusted EPS- | ROIC- | TSR- | ||
base number of shares at 100% payout | Total | condition | condition | condition |
Conditionally awarded grant 2022 | 303,253 | 88,324 | 58,886 | 156,043 |
Forfeited in previous years | (562) | (169) | (112) | (281) |
Shares outstanding at January 1, 2023 | 302,691 | 88,155 | 58,774 | 155,762 |
Forfeited during the year | (19,211) | (5,761) | (3,841) | (9,609) |
Shares outstanding at December 31, 2023 | 283,480 | 82,394 | 54,933 | 146,153 |
LTIP 2023-25 | Adjusted EPS- | ROIC- | TSR- | |
base number of shares at 100% payout | Total | condition | condition | condition |
Conditionally awarded grant 2023 | 338,699 | 98,605 | 65,708 | 174,386 |
Forfeited during the year | (989) | (297) | (198) | (494) |
Shares outstanding at December 31, 2023 | 337,710 | 98,308 | 65,510 | 173,892 |
Overview of outstanding performance shares: LTIP 2022-24 and LTIP 2023-25 | ||||
base numbers of shares at 100% payout | LTIP 2022-24 | LTIP 2023-25 | Total | |
Conditionally awarded grant 2022 | 303,253 | – | 303,253 | |
Forfeited in previous years | (562) | – | (562) | |
Shares outstanding at January 1, 2023 | 302,691 | 0 | 302,691 | |
Conditionally awarded grant 2023 | – | 338,699 | 338,699 | |
Forfeited during the year | (19,211) | (989) | (20,200) | |
Shares outstanding at December 31, 2023 | 283,480 | 337,710 | 621,190 |
Fair value | Fair value | Fair value | |
RSU shares | RSU shares | RSU shares | |
at grant date | at grant date | at grant date | |
in euros | March 1 | July 1 | November 1 |
RSU shares 2023 – one-year vesting period | 107.56 | 114.26 | 118.96 |
RSU shares 2023 – two-years vesting period | 105.46 | 111.98 | 116.55 |
RSU shares 2023 – three-years vesting period | 103.11 | 109.43 | 113.86 |
Grant date | Grant date | Grant date | ||
Conditionally awarded number of RSU shares, | Total number | March 1, | July 1, | November 1, |
grant 2023 | of RSU shares | 2023 | 2023 | 2023 |
One-year vesting period | 11,951 | 333 | 589 | |
Two-years vesting period | 11,924 | 332 | 589 | |
Three-years vesting period | 11,832 | 332 | 588 | |
Total shares conditionally awarded | 38,470 | 35,707 | 997 | 1,766 |
Forfeitures during the year | (928) | (928) | – | – |
Shares outstanding at December 31, 2023 | 37,542 | 34,779 | 997 | 1,766 |
Audit fees 2023 | |||
Other Deloitte | |||
Deloitte | member firms and | ||
Accountants B.V. | affiliates | Total Deloitte | |
Statutory audit of annual accounts | 1.0 | 2.3 | 3.3 |
Other assurance services | 0.1 | 0.3 | 0.4 |
Tax advisory services | – | 0.0 | 0.0 |
Other non-audit services | – | 0.0 | 0.0 |
Total | 1.1 | 2.6 | 3.7 |
Audit fees 2022 | Other Deloitte | ||
Deloitte | member firms and | ||
Accountants B.V. | affiliates | Total Deloitte | |
Statutory audit of annual accounts | 1.0 | 2.0 | 3.0 |
Other assurance services | 0.1 | 0.1 | 0.2 |
Tax advisory services | – | 0.0 | 0.0 |
Other non-audit services | – | 0.0 | 0.0 |
Total | 1.1 | 2.1 | 3.2 |
2023 | 2022 | ||
Parental performance guarantees to third parties | 5 | 5 | |
Guarantee to the trustees of the U.K. retirement plan | Note 30 | 21 | 20 |
Real estate and other guarantees | 11 | 11 | |
Drawn bank credit facilities | 1 | 1 | |
Total | 38 | 37 |
in thousands of euros | 2023 | 2022 | ||
Fixed compensation: | ||||
Salary | 2,308 | 2,260 | ||
Social security | 247 | 123 | ||
Defined contribution plan | 180 | 176 | ||
Other benefits | 400 | 385 | ||
Total fixed compensation | 3,135 | 2,944 | ||
Variable compensation: | ||||
STIP | 2,736 | 2,818 | ||
LTIP | 6,307 | 6,405 | ||
Total variable compensation | 9,043 | 9,223 | ||
Sub-total fixed and variable compensation | 12,178 | 12,167 | ||
Tax-related costs | (459) | (525) | ||
Total remuneration Executive Board | 11,719 | 11,642 |